Matches in Nanopublications for { ?s ?p "DDI between Voriconazole and Rifapentine - Rifapentine may decrease the serum concentration of voriconazole likely by increasing its metabolism via CYP3A enzymes. Voriconazole may increase the serum concentration of rifapentin likely by inhibiting its metabolism via CYP3A. Concomitant therapy is contraindicated. [drugbank_resource:DB00582_DB01201]"@en ?g. }
Showing items 1 to 1 of
1
with 100 items per page.
- drugbank_resource:DB00582_DB01201 label "DDI between Voriconazole and Rifapentine - Rifapentine may decrease the serum concentration of voriconazole likely by increasing its metabolism via CYP3A enzymes. Voriconazole may increase the serum concentration of rifapentin likely by inhibiting its metabolism via CYP3A. Concomitant therapy is contraindicated. [drugbank_resource:DB00582_DB01201]" assertion.